• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    Merck KGaA, Quris-AI Expand Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC

    Sartorius, SPARTA Biodiscovery Partner on Nanoparticle Analysis Platform

    Peptone Expands Leadership Team with Key Executive Hires
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    U.S. Pharmacopeia (USP)

    CMC Pharmaceuticals

    Quotient Sciences

    Lannett CDMO

    Societal CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    U.S. Pharmacopeia (USP)

    CMC Pharmaceuticals

    Quotient Sciences

    Lannett CDMO

    Societal CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Sterile Fill/Finish CDMO swissfillon Joins ten23 health

    ten23 health’s new combination of pharma development services with clinical & commercial fill/finish services will offer customers an end-to-end capabilities.

    Sterile Fill/Finish CDMO swissfillon Joins ten23 health
    10.25.21
    ten23 health, a global contract development and manufacturing organization (CDMO), has acquired swissfillon AG, located in Visp, Switzerland. swissfillon will join ten23 to enhance the companies’ integrated offering of drug product development services and fill-finish manufacturing to their combined group of customers.
     
    swissfillon is a leader in the sterile filling of complex pharmaceuticals into innovative containers and devices. The company, which was founded in 2013, employs over 50 people and is a specialized player in the global CDMO market. swissfillon’s operations have been approved by Swissmedic for the European market since 2018 and by the FDA for the U.S. market since 2019. The company currently supports various clinical and early commercial customer programs.
     
    The combined business of ten23 health and swissfillon will provide an integrated offering for sterile drug product development and manufacturing of biologics, challenging molecules and dosage forms. swissfillon will continue to operate under its brand, which stands for first-class Swiss quality and excellent know-how. Prof. Dr. Hanns-Christian Mahler will serve as CEO of the combined entities under the ten23 health umbrella. Daniel Kehl, founder of swissfillon, will remain with the business in a key leadership role and will help to lead ten23’s new infrastructure engineering projects that are of great strategic importance for the further development of the combined offering.
     
    swissfillon manufactures sterile dosage forms—usually a syringe, cartridge or vial—which allow a drug substance to be administered to a patient to meet the increasing market demand for complex products and patient centric application forms. Biologics are sensitive to temperature and manufacturing stresses and are often developed for applications such as intraocular or subcutaneous injection, requiring specific expertise in both development and manufacturing.
     
    swissfillon´s latest generation fill/finish technologies allow very small quantities to be filled, while minimizing losses of these very expensive drugs. swissfillon also has a specialized expertise in bubble-free filling, ensuring dose precision and product safety, specifically relevant for subcutaneous and intravitreal injetions. Last year, swissfillon also supplied 0.8 million aseptically filled transport media in syringes for the Swiss army pharmacy’s COVID-19 PCR test kit related to the urgent provision of testing capabilities.
     
    “We look forward to join ten23 health’s world-class team. There is a great strategic fit between our profound expertise in sterile drug product manufacturing for complex pharmaceuticals and ten23 health’s focus on the development and manufacturing of injectable treatments,” said Daniel Kehl, current CEO of swissfillon. “By pooling our profound expertise, we will be able to further expand our market position for injectable treatments. The swissfillon team looks forward to continue advancing under the ten23 health umbrella and providing our combined group of customers with excellent support and customizable solutions.”
     
    Hanns-Christian Mahler, CEO of ten23 health, said, “Sterile fill and finish services are expected to experience significant growth over the coming years. The rising demand is driven by expanded drug development pipelines, incorporating more complex, large-molecule products and therapies that require specific expertise for both development and sterile production. This is precisely why we expect ten23 health´s services, now including swissfillon, to be in great demand. At ten23 health, we are very pleased that we can now offer this sought-after know-how to biotech startups and pharmaceutical companies from one single source.”
      Loading, Please Wait..
      Breaking News
      • Univercells Expands into the U.S. With New Offices in Andover, MA
      • Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat
      • Sanner Group Opens Second Manufacturing Facility in China
      • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
      • Merck KGaA, Quris-AI Expand Collaboration
      View Breaking News >
      CURRENT ISSUE

      September 2023

      • Pharma Supply Chains: From Fragile to Agile
      • Overcoming Stressors in Knowledge Transfer
      • Innovations in Pharma Packaging
      • HPAPI Manufacturing Trends
      • Sustainable Packaging in Pharma: No Longer a Pipe Dream
      • Revolutionizing Pharma’s Supply Chain
      • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
      • Solving Pharma’s Underlying Rebate Leakage Problem
      • Advanced Manufacturing and a Roadmap to the Facility of the Future
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      PLT Health Solutions Granted Claims for Botanical Ingredient in Canada
      CRN Files Petition with FTC For Clarity on Health Products Compliance Guidance
      Vitafoods Europe Relocates to Barcelona Starting 2025
      Coatings World

      Latest Breaking News From Coatings World

      California Sports Surfaces Celebrates 70 Years
      ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
      AkzoNobel Shares Sustainable Architectural Solutions at Conference
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
      ResMed, Nyxoah Team Up to Grow Sleep Apnea Awareness & Therapy in Germany
      Siemens Healthineers’ Magnetom Viato.Mobile Cleared by FDA
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Univercells Expands into the U.S. With New Offices in Andover, MA
      Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat
      Sanner Group Opens Second Manufacturing Facility in China
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
      74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
      Stoelzle Glass Group Names New CEO
      Happi

      Latest Breaking News From Happi

      Breakfast with Oral Care Benefits?
      Stanford Researchers Study Skin and Sensorial Perception
      L’Oréal Awarded US Patent for Makeup
      Ink World

      Latest Breaking News From Ink World

      Siegwerk’s Climate Targets Validated by SBTi
      ROSS Offering Cost-Effective, Expertly Reconditioned Equipment
      Amcor plc Adds Lucrèce Foufopoulos-De Ridder to Board of Directors
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      SABIC and partners launch bio-based IML solution for food packaging
      tesa completes expansion of Michigan manufacturing facility
      Comexi and Asahi to host 'Effortless Platemaking' event
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Greentech Introduces Air Filter with Advanced Odor Elimination
      Ontex Divests Pakistan Operations to ASAIA Holding
      Goodnites Bedwetting Underwear Recognized by Good Housekeeping
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      ChitogenX Granted New U.S., Canadian ORTHO-R Patent
      Centinel Spine prodisc System Surpasses 2,500-Implant Milestone
      Medacta Completes First U.S. MyPAO Hip Surgery
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
      Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More
      SCHOTT Strengthens Glass Substrate Portfolio

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login